Synopsis
Confirm pleural chyle biochemically, distinguish it from pseudochylothorax, find traumatic or non-traumatic causes, protect nutrition and immunity, and escalate a persistent leak to specialist lymphatic intervention.
- Chylothorax is lymph rich in chylomicrons entering the pleural space after disruption or obstruction of the thoracic lymphatic system; appearance alone cannot confirm it.
- Pleural fluid triglyceride above 1.24 mmol/L supports chylothorax, and demonstration of chylomicrons by lipoprotein analysis is the reference test when biochemical results are equivocal.
- Pseudochylothorax develops in a longstanding effusion, commonly with tuberculosis or rheumatoid pleuritis, and is characterised by high cholesterol, cholesterol crystals and absent chylomicrons.
Key red flags
New pleural drainage that increases or becomes creamy after enteral feeding following oesophagectomy, mediastinal surgery, cardiac surgery or neck dissection is highly suggestive. Record the operation, side, daily volume and relation to feeding.
Investigation priorities
Confirm a safely accessible effusion, identify septation and guide sampling or drainage.
Management branches
Milky fluid, an unexplained lymphocytic effusion or new output after thoracic or neck surgery.
- Use thoracic ultrasound for aspiration, send triglyceride and cholesterol, and request chylomicron analysis when the biochemical pattern is borderline or clinical suspicion remains high.
- Build a timeline around surgery, trauma, feeding and central venous access; examine for lymphadenopathy and review for lymphoma, other cancer, venous thrombosis, cirrhosis, tuberculosis and lymphatic disorders.
The patient is stable and a time-limited conservative trial is clinically reasonable.
Key medicines
Octreotide as an adjunct in selected chyle leaksThere is no nationally standard adult chylothorax regimen. If used, prescribe an expert-centre protocol with pharmacy review and a documented output-based stop rule; use is off-label.